Core Book Value Per Share vs Pb Ratio Analysis

CORZZ Stock

8.68 0.21 2.48%

Core Scientific, financial indicator trend analysis is way more than just evaluating Core Scientific, Tranche prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Core Scientific, Tranche is a good investment. Please check the relationship between Core Scientific, Book Value Per Share and its Pb Ratio accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Scientific, Tranche. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Book Value Per Share vs Pb Ratio

Book Value Per Share vs Pb Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Core Scientific, Tranche Book Value Per Share account and Pb Ratio. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Core Scientific,'s Book Value Per Share and Pb Ratio is 0.47. Overlapping area represents the amount of variation of Book Value Per Share that can explain the historical movement of Pb Ratio in the same time period over historical financial statements of Core Scientific, Tranche, assuming nothing else is changed. The correlation between historical values of Core Scientific,'s Book Value Per Share and Pb Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Book Value Per Share of Core Scientific, Tranche are associated (or correlated) with its Pb Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Pb Ratio has no effect on the direction of Book Value Per Share i.e., Core Scientific,'s Book Value Per Share and Pb Ratio go up and down completely randomly.

Correlation Coefficient

0.47

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Pb Ratio

Most indicators from Core Scientific,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Core Scientific, Tranche current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Scientific, Tranche. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

At this time, Core Scientific,'s Tax Provision is fairly stable compared to the past year. Issuance Of Capital Stock is likely to rise to about 58.9 M in 2025, whereas Selling General Administrative is likely to drop slightly above 95.2 M in 2025.

	2023	2024	2025 (projected)
Interest Expense	37.1M	42.6M	49.3M
Depreciation And Amortization	120.1M	138.1M	145.0M

Interest Expense Depreciation And Amortization

Core Scientific, fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Current Deferred Revenue
Total Assets		0.82	0.49	0.63	0.04	0.85	0.77	-0.6	0.15	0.64	0.95	0.81	-0.35	0.81	0.65	0.28	0.65	0.73	0.75	0.76	0.77	0.86	0.51	0.1	0.66	0.28
Short Long Term Debt Total	0.82		0.64	0.7	-0.48	0.94	0.73	-0.92	0.4	0.85	0.77	0.91	-0.65	1.0	0.85	0.45	0.85	0.96	0.34	0.99	0.98	0.89	0.56	-0.34	0.19	-0.27
Other Current Liab	0.49	0.64		0.87	-0.36	0.62	0.89	-0.62	0.79	0.42	0.5	0.72	-0.27	0.62	0.41	0.94	0.66	0.52	0.24	0.6	0.6	0.46	0.58	-0.18	0.12	-0.22
Total Current Liabilities	0.63	0.7	0.87		-0.12	0.76	0.93	-0.55	0.81	0.29	0.76	0.79	-0.24	0.66	0.29	0.88	0.83	0.49	0.5	0.61	0.59	0.45	0.87	-0.06	0.41	-0.01
Total Stockholder Equity	0.04	-0.48	-0.36	-0.12		-0.37	-0.06	0.77	-0.38	-0.58	0.17	-0.32	0.44	-0.5	-0.58	-0.26	-0.44	-0.59	0.65	-0.58	-0.57	-0.28	-0.04	0.87	0.76	0.96
Property Plant And Equipment Net	0.85	0.94	0.62	0.76	-0.37		0.75	-0.85	0.5	0.65	0.83	0.9	-0.39	0.92	0.66	0.46	0.93	0.83	0.4	0.89	0.87	0.75	0.74	-0.34	0.29	-0.2
Net Debt	0.77	0.73	0.89	0.93	-0.06	0.75		-0.56	0.65	0.45	0.8	0.77	-0.28	0.7	0.44	0.82	0.73	0.57	0.61	0.65	0.65	0.62	0.67	0.02	0.51	0.12
Retained Earnings	-0.6	-0.92	-0.62	-0.55	0.77	-0.85	-0.56		-0.45	-0.84	-0.5	-0.8	0.58	-0.93	-0.85	-0.43	-0.8	-0.94	0.02	-0.95	-0.94	-0.75	-0.43	0.62	0.17	0.59
Accounts Payable	0.15	0.4	0.79	0.81	-0.38	0.5	0.65	-0.45		0.01	0.28	0.45	0.01	0.36	0.01	0.9	0.73	0.22	-0.04	0.35	0.31	0.01	0.77	-0.43	-0.07	-0.39
Cash	0.64	0.85	0.42	0.29	-0.58	0.65	0.45	-0.84	0.01		0.47	0.68	-0.79	0.88	1.0	0.15	0.48	0.96	0.13	0.9	0.93	0.93	0.03	-0.33	-0.04	-0.34
Non Current Assets Total	0.95	0.77	0.5	0.76	0.17	0.83	0.8	-0.5	0.28	0.47		0.82	-0.3	0.75	0.47	0.38	0.71	0.61	0.83	0.68	0.67	0.73	0.7	0.2	0.76	0.35
Non Currrent Assets Other	0.81	0.91	0.72	0.79	-0.32	0.9	0.77	-0.8	0.45	0.68	0.82		-0.48	0.9	0.68	0.55	0.79	0.82	0.46	0.87	0.87	0.78	0.67	-0.09	0.3	-0.14
Other Assets	-0.35	-0.65	-0.27	-0.24	0.44	-0.39	-0.28	0.58	0.01	-0.79	-0.3	-0.48		-0.68	-0.79	-0.16	-0.32	-0.75	-0.07	-0.71	-0.73	-0.72	0.01	0.18	0.09	0.31
Long Term Debt	0.81	1.0	0.62	0.66	-0.5	0.92	0.7	-0.93	0.36	0.88	0.75	0.9	-0.68		0.88	0.42	0.82	0.98	0.32	1.0	0.99	0.91	0.5	-0.35	0.16	-0.29
Cash And Short Term Investments	0.65	0.85	0.41	0.29	-0.58	0.66	0.44	-0.85	0.01	1.0	0.47	0.68	-0.79	0.88		0.15	0.49	0.96	0.13	0.91	0.93	0.93	0.04	-0.34	-0.05	-0.35
Net Receivables	0.28	0.45	0.94	0.88	-0.26	0.46	0.82	-0.43	0.9	0.15	0.38	0.55	-0.16	0.42	0.15		0.61	0.29	0.18	0.4	0.38	0.2	0.64	-0.15	0.1	-0.2
Common Stock Shares Outstanding	0.65	0.85	0.66	0.83	-0.44	0.93	0.73	-0.8	0.73	0.48	0.71	0.79	-0.32	0.82	0.49	0.61		0.7	0.24	0.8	0.76	0.53	0.85	-0.49	0.15	-0.33
Non Current Liabilities Total	0.73	0.96	0.52	0.49	-0.59	0.83	0.57	-0.94	0.22	0.96	0.61	0.82	-0.75	0.98	0.96	0.29	0.7		0.19	0.99	0.99	0.93	0.31	-0.4	0.02	-0.37
Other Current Assets	0.75	0.34	0.24	0.5	0.65	0.4	0.61	0.02	-0.04	0.13	0.83	0.46	-0.07	0.32	0.13	0.18	0.24	0.19		0.23	0.24	0.48	0.4	0.67	0.98	0.8
Other Stockholder Equity	0.76	0.99	0.6	0.61	-0.58	0.89	0.65	-0.95	0.35	0.9	0.68	0.87	-0.71	1.0	0.91	0.4	0.8	0.99	0.23		1.0	0.89	0.45	-0.41	0.07	-0.37
Total Liab	0.77	0.98	0.6	0.59	-0.57	0.87	0.65	-0.94	0.31	0.93	0.67	0.87	-0.73	0.99	0.93	0.38	0.76	0.99	0.24	1.0		0.92	0.4	-0.38	0.07	-0.35
Total Current Assets	0.86	0.89	0.46	0.45	-0.28	0.75	0.62	-0.75	0.01	0.93	0.73	0.78	-0.72	0.91	0.93	0.2	0.53	0.93	0.48	0.89	0.92		0.2	-0.06	0.32	-0.02
Short Term Debt	0.51	0.56	0.58	0.87	-0.04	0.74	0.67	-0.43	0.77	0.03	0.7	0.67	0.01	0.5	0.04	0.64	0.85	0.31	0.4	0.45	0.4	0.2		-0.14	0.38	-0.03
Intangible Assets	0.1	-0.34	-0.18	-0.06	0.87	-0.34	0.02	0.62	-0.43	-0.33	0.2	-0.09	0.18	-0.35	-0.34	-0.15	-0.49	-0.4	0.67	-0.41	-0.38	-0.06	-0.14		0.7	0.88
Common Stock	0.66	0.19	0.12	0.41	0.76	0.29	0.51	0.17	-0.07	-0.04	0.76	0.3	0.09	0.16	-0.05	0.1	0.15	0.02	0.98	0.07	0.07	0.32	0.38	0.7		0.88
Current Deferred Revenue	0.28	-0.27	-0.22	-0.01	0.96	-0.2	0.12	0.59	-0.39	-0.34	0.35	-0.14	0.31	-0.29	-0.35	-0.2	-0.33	-0.37	0.8	-0.37	-0.35	-0.02	-0.03	0.88	0.88

Click cells to compare fundamentals

Core Scientific, Account Relationship Matchups

Core Scientific, fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	2.4B	807.7M	712.2M	1.6B	1.8B	1.1B
Short Long Term Debt Total	40.3M	818.8M	865.5M	1.2B	1.4B	1.4B
Other Current Liab	56.6M	1.6M	175.9M	69.2M	79.6M	66.0M
Total Current Liabilities	320.3M	186.8M	488.4M	134.6M	154.7M	223.5M
Total Stockholder Equity	1.4B	(409.3M)	(596.9M)	(820.2M)	(738.2M)	(701.3M)
Property Plant And Equipment Net	597.3M	711.6M	593.3M	670.8M	771.4M	502.8M
Net Debt	687.1M	20.4M	815.1M	363.6M	418.1M	351.5M
Retained Earnings	(27.4M)	(2.2B)	(2.4B)	(3.7B)	(3.4B)	(3.2B)
Accounts Payable	11.6M	53.6M	154.8M	19.3M	22.2M	21.0M
Cash	131.7M	15.9M	50.4M	836.2M	961.6M	1.0B
Non Current Assets Total	1.7B	722.6M	615.1M	694.9M	799.1M	720.9M
Non Currrent Assets Other	21.0M	9.3M	19.6M	24.0M	27.6M	29.0M
Long Term Debt	19.9M	652.2M	684.1M	1.1B	1.2B	1.3B
Cash And Short Term Investments	8.7M	131.7M	50.4M	836.2M	961.6M	1.0B
Net Receivables	1.7M	257K	7.2M	1.0M	1.2M	2.1M
Common Stock Shares Outstanding	233.3M	375.2M	379.9M	255.8M	294.2M	254.1M
Liabilities And Stockholders Equity	225.6M	2.4B	712.2M	1.6B	1.8B	1.1B
Non Current Liabilities Total	732.9M	1.0B	820.7M	2.3B	2.6B	2.8B
Other Current Assets	637.0M	4.0M	39.4M	66.7M	60.1M	108.3M
Other Stockholder Equity	164.0M	1.3B	1.8B	2.9B	3.4B	3.5B
Total Liab	1.1B	1.2B	1.3B	2.4B	2.8B	2.9B
Total Current Assets	756.6M	85.1M	97.0M	904.0M	1.0B	1.1B
Short Term Debt	18.2M	104.4M	144.2M	27.9M	32.1M	30.5M
Intangible Assets	6.7M	8.2M	1.7M	2.2M	2.0M	3.6M
Capital Lease Obligations	90.6M	1.5M	57.1M	109.5M	125.9M	132.2M
Net Invested Capital	2.1B	(373.1M)	211.5M	270.1M	243.1M	368.5M
Property Plant And Equipment Gross	644.3M	979.8M	887.2M	1.1B	1.2B	807.3M
Short Long Term Debt	76.0M	36.2M	124.4M	16.3M	18.7M	17.8M
Non Current Liabilities Other	18.5M	1.0B	99.3M	15.3M	17.6M	16.7M
Net Working Capital	436.3M	(101.7M)	(391.4M)	769.4M	884.8M	929.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

AMT	American Tower Corp
HLTOY	Hellenic Telecommunications Org
NFLX	Netflix

Additional Tools for Core Stock Analysis

When running Core Scientific,'s price analysis, check to measure Core Scientific,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Scientific, is operating at the current time. Most of Core Scientific,'s value examination focuses on studying past and present price action to predict the probability of Core Scientific,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Scientific,'s price. Additionally, you may evaluate how the addition of Core Scientific, to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Core Book Value Per Share vs Pb Ratio Analysis

Book Value Per Share vs Pb Ratio

Book Value Per Share vs Pb Ratio Correlation Analysis

Correlation Coefficient

Book Value Per Share

Pb Ratio

Core Scientific, fundamental ratios Correlations

Core Scientific, Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Core Scientific, fundamental ratios Accounts

Also Currently Popular

Additional Tools for Core Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Long Term Debt	+ 1.0	Short Long Term Debt Total
Cash And Short Term Investments	+ 1.0	Cash
Other Stockholder Equity	+ 1.0	Long Term Debt
Total Liab	+ 1.0	Other Stockholder Equity
Other Stockholder Equity	+ 0.99	Short Long Term Debt Total
Total Liab	+ 0.99	Long Term Debt

Other Stockholder Equity	- 0.95	Retained Earnings
Total Liab	- 0.94	Retained Earnings
Non Current Liabilities Total	- 0.94	Retained Earnings
Long Term Debt	- 0.93	Retained Earnings
Retained Earnings	- 0.92	Short Long Term Debt Total
Cash And Short Term Investments	- 0.85	Retained Earnings